Medical Research Center, China Academy of Chinese Medical Science, Beijing, China; Development Research Center of TCM, China Academy of Chinese Medical Science, Beijing, China.
School of Pharmacy, Inner Mongolia Medical University, Hohhot, China.
J Ethnopharmacol. 2021 May 10;271:113877. doi: 10.1016/j.jep.2021.113877. Epub 2021 Jan 27.
Pomegranate, Punica granatum L., has been used in traditional medicine in China and several regions of the world including Ayurveda, Islamic, and Persian for the treatment of atherosclerosis, diabetes, hypertension, hyperlipidemia, and several types of cancer, as well as for peptic ulcer and oral diseases for hundreds of years. Presently, pomegranate is treated as both a "medicine food homology" herbal medicine and a healthy food supplemental product.
The aim of this work is to develop an overview of pomegranate in the context of the status of its traditional medicine theories, the spread along the Silk Road, ethnopharmacological uses, chemical compositions, pharmacological activities, toxicology, and the involved pathways.
Information on P. granatum L. was acquired from published materials, including monographs on medicinal plants, ancient and modern recorded classical texts; and pharmacopoeias and electronic databases (PubMed, Science Direct, Web of Science, Google Scholar, CNKI, and Wanfang Data).
Pomegranate has been used in many traditional medical systems throughout history. It is widely cultivated in Central Asia and spread throughout China along the Silk Road. Many phytochemicals, such as tannins, organic acids, flavonoids, alkaloids, and volatile oils have been identified from different parts of pomegranate, these compounds have a wide range of activities, including antioxidant, antimicrobial, and anti-oncogenic properties, as well as conferring resistance to cerebrovascular disease. Furthermore, A summary of the four promising pharmacological pathways is provided.
The traditional uses, chemical compositions, pharmacological activities, and signaling pathways of pomegranate are summarized comprehensively in the review. It can be treated as a guidance for the future clinical and basic research. The information provided in this review will be very useful for further studies to develop novel therapeutic directions for application of pomegranate.
石榴,Punica granatum L.,在中国和世界上包括印度教、伊斯兰教和波斯医学在内的几个地区,已被用于治疗动脉粥样硬化、糖尿病、高血压、高脂血症和多种癌症以及消化性溃疡和口腔疾病等数百年来。目前,石榴被视为一种“药食同源”的草药和健康食品补充剂。
本研究旨在综述石榴在传统医学理论、丝绸之路传播、民族药理学用途、化学成分、药理活性、毒理学以及相关途径方面的地位。
从已发表的材料中获取关于石榴的信息,包括药用植物专着、古代和现代记录的经典文本;以及药典和电子数据库(PubMed、Science Direct、Web of Science、Google Scholar、CNKI 和万方数据)。
石榴在历史上被许多传统医学体系使用。它在中亚广泛种植,并沿着丝绸之路在中国传播。从石榴的不同部位已经鉴定出许多植物化学物质,如单宁、有机酸、类黄酮、生物碱和挥发油,这些化合物具有广泛的活性,包括抗氧化、抗菌和抗癌特性,以及对脑血管疾病的抗性。此外,还提供了四个有前途的药理途径的总结。
综述全面总结了石榴的传统用途、化学成分、药理活性和信号通路。它可以作为未来临床和基础研究的指导。本综述提供的信息对于进一步研究开发石榴的新治疗方向将非常有用。